Stillwater Scientific Instruments, a developer and manufacturer of advanced analytical instrumentation, announces that Stephen Martin has joined its board of directors.
Martin is senior vice president and chief technology officer of BG Medicine, an emerging biotechnology company based in Waltham, MA, and brings a wealth of commercial and research experience in mass spectrometry to Stillwater Scientific.
"We are excited to have Steve's strong technical background and competitive market experience as we continue to develop our products and explore opportunities for our mass spectrometry technology," says Brian Frederick, co-founder of Stillwater Scientific.
"Steve has practical experience leading scientific and engineering development teams in commercial environments to consistently deliver high-quality instruments that solve customer problems.
"He will provide invaluable insight to our growing company".
"Continued innovation is a key to the broader acceptance of mass spectrometry as an analytical platform for life science and broader chemical analysis," says Martin.
"Stillwater's technology has the potential to dramatically improve the performance and practical applications of mass spectrometry for the scientific community and I am looking forward to sharing my experience with Brian and his team as they aggressively develop their products".
Martin has held senior-level management and leadership roles with pioneering companies in the mass spectrometry market.
Martin was senior director of the discovery proteomics and small molecule research centre at Applied Biosystems, where he helped the company develop its leading mass spectrometer instrument.
He and his team worked with collaborators in a variety of applications to help them apply the technology to their most pressing problems and get the information they needed.
In addition, Martin also was a member of the structural biochemistry department at the Genetics Institute, now Wyeth Pharmaceuticals.
In his academic career, Martin served in several roles associated with the department of chemistry at Massachusetts Institute of Technology, including as the Assistant Director at the National Institutes of Health Mass Spectrometry Facility.
Martin received his BA in chemistry from Boston University, and his PhD in analytical chemistry from MIT.
Based in Orono, ME, Stillwater Technologies's patented time-of-flight (TOF) method can be used for analytical instruments, such as mass spectrometers and scientific research instruments that measure electron energy.
The company developed the technology at the Laboratory for Surface Science and Technology at the University of Maine, and was initially funded by a grant from the US National Science Foundation.
It received additional funding from the Maine Technology Institute, the Maine Manufacturing Extension Partnership and also received support from the Target Technology Center in Orono, ME and the Small Business Technology Development Center.
In 2004, Stillwater engaged with Launch Momentum, a Falmouth, ME-based business development and technology commercialisation firm, to provide strategic consultation and tactical implementation needed to bring its products to market.
